Search Results

There are 1095 results for: content related to: Combined analysis of three crossover clinical pharmacology studies of effects of rabeprazole and esomeprazole on 24-h intragastric pH in healthy volunteers

  1. You have free access to this content
    An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers

    Alimentary Pharmacology & Therapeutics

    Volume 33, Issue 7, April 2011, Pages: 845–854, G. Morelli, H. Chen, G. Rossiter, B. Rege and Y. Lu

    Version of Record online : 28 JAN 2011, DOI: 10.1111/j.1365-2036.2011.04580.x

  2. The chiral bioconversion and preclinical pharmacokinetic analysis of (R)-(+)-rabeprazole in beagle dogs by HPLC and HPLC-MS/MS

    Biomedical Chromatography

    Volume 27, Issue 11, November 2013, Pages: 1380–1386, Yan-hui Gao, Jia-xing Xu, Zhong-xue Su, Li Song and Hong-xiang Lou

    Version of Record online : 22 MAY 2013, DOI: 10.1002/bmc.2932

  3. Improvement of meal-related symptoms and epigastric pain in patients with functional dyspepsia treated with acotiamide was associated with acylated ghrelin levels in Japan

    Neurogastroenterology & Motility

    Volume 28, Issue 7, July 2016, Pages: 1037–1047, H. Yamawaki, S. Futagami, T. Kawagoe, Y. Maruki, S. Hashimoto, H. Nagoya, H. Sato, Y. Kodaka, K. Gudis, T. Akamizu, C. Sakamoto and K. Iwakiri

    Version of Record online : 27 FEB 2016, DOI: 10.1111/nmo.12805

  4. You have free access to this content
    Different effects of fluvoxamine on rabeprazole pharmacokinetics in relation to CYP2C19 genotype status

    British Journal of Clinical Pharmacology

    Volume 61, Issue 3, March 2006, Pages: 309–314, Tsukasa Uno, Mikiko Shimizu, Norio Yasui-Furukori, Kazunobu Sugawara and Tomonori Tateishi

    Version of Record online : 1 DEC 2005, DOI: 10.1111/j.1365-2125.2005.02556.x

  5. You have free access to this content
    Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin

    Alimentary Pharmacology & Therapeutics

    Volume 40, Issue 7, October 2014, Pages: 780–795, R. Iwakiri, K. Higuchi, M. Kato, M. Fujishiro, Y. Kinoshita, T. Watanabe, T. Takeuchi, M. Yamauchi, M. Sanomura, H. Nakagawa, N. Sugisaki, Y. Okada, H. Ogawa, T. Arakawa and K. Fujimoto

    Version of Record online : 6 AUG 2014, DOI: 10.1111/apt.12907

  6. You have free access to this content
    Review article: pH, healing and symptom relief with rabeprazole treatment in acid-related disorders

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue s6, November 2004, Pages: 30–37, M. Robinson

    Version of Record online : 19 OCT 2004, DOI: 10.1111/j.1365-2036.2004.02163.x

  7. Pharmacokinetics of rabeprazole granules versus tablets, and the effect of food on the pharmacokinetics of rabeprazole granules in healthy adults—cross-study comparison

    Clinical Pharmacology in Drug Development

    Volume 3, Issue 5, September/October 2014, Pages: 406–416, An Thyssen, Bhavna Solanki, Martha Gonzalez, Gerhard Leitz, William Treem and Erik Mannaert

    Version of Record online : 23 MAY 2014, DOI: 10.1002/cpdd.118

  8. You have free access to this content
    Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States

    Alimentary Pharmacology & Therapeutics

    Volume 22, Issue 3, August 2005, Pages: 193–202, A. CAOS, J. BREITER, C. PERDOMO and J. BARTH

    Version of Record online : 29 JUL 2005, DOI: 10.1111/j.1365-2036.2005.02555.x

  9. You have free access to this content
    Review article: rabeprazole’s profile in patients with gastrointestinal diseases

    Alimentary Pharmacology & Therapeutics

    Volume 13, Issue s5, October 1999, Pages: 25–32, Humphries and Barth

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2036.1999.00036.x

  10. Review article: comparative pharmacodynamic review of rabeprazole – focus on day 1 data

    Alimentary Pharmacology & Therapeutics Symposium Series

    Volume 2, Issue 2, July 2006, Pages: 315–326, M. ROBINSON and J. BARONE

    Version of Record online : 26 JUN 2006, DOI: 10.1111/j.1746-6342.2006.00062.x

  11. You have free access to this content
    Rabeprazole-based therapies in Helicobacter pylori eradication

    Alimentary Pharmacology & Therapeutics

    Volume 17, Issue 6, March 2003, Pages: 751–764, J. P. Gisbert, S. Khorrami, X. Calvet and J. M. Pajares

    Version of Record online : 17 MAR 2003, DOI: 10.1046/j.1365-2036.2003.01450.x

  12. Review article: understanding the pharmacodynamic and pharmacokinetic differences between proton pump inhibitors – focus on pKa and metabolism

    Alimentary Pharmacology & Therapeutics Symposium Series

    Volume 2, Issue 2, July 2006, Pages: 340–350, J. HORN

    Version of Record online : 26 JUN 2006, DOI: 10.1111/j.1746-6342.2006.00065.x

  13. You have free access to this content
    Effects of a single dose of rabeprazole 20 mg and pantoprazole 40 mg on 24-h intragastric acidity and oesophageal acid exposure: a randomized study in gastro-oesophageal reflux disease patients with a history of nocturnal heartburn

    Alimentary Pharmacology & Therapeutics

    Volume 31, Issue 9, May 2010, Pages: 991–1000, P. MINER, B. DELEMOS, J. XIANG, J. LOCOCO and J. IENI

    Version of Record online : 2 FEB 2010, DOI: 10.1111/j.1365-2036.2010.04255.x

  14. You have free access to this content
    Review article: relationship between the metabolism and efficacy of proton pump inhibitors – focus on rabeprazole

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue s6, November 2004, Pages: 11–19, J. Horn

    Version of Record online : 19 OCT 2004, DOI: 10.1111/j.1365-2036.2004.02161.x

  15. You have free access to this content
    Pharmacodynamic effects and kinetic disposition of rabeprazole in relation to CYP2C19 genotypes

    Alimentary Pharmacology & Therapeutics

    Volume 15, Issue 6, June 2001, Pages: 793–803, Y. Horai, M. Kimura, H. Furuie, K. Matsuguma, S. Irie, Y. Koga, T. Nagahama, M. Murakami, T. Matsui, T. Yao, A. Urae and T. Ishizaki

    Version of Record online : 12 JAN 2002, DOI: 10.1046/j.1365-2036.2001.00980.x

  16. You have free access to this content
    Decreasing oesophageal acid exposure in patients with GERD: a comparison of rabeprazole and omeprazole

    Alimentary Pharmacology & Therapeutics

    Volume 15, Issue 9, September 2001, Pages: 1343–1350, J. P. Galmiche, F. Zerbib, P. Ducrottè, J. Fournet, P. Rampal, N. Avasthy and T. J. Humphries

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1365-2036.2001.01030.x

  17. You have free access to this content
    Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes

    British Journal of Clinical Pharmacology

    Volume 61, Issue 3, March 2006, Pages: 315–320, Masatomo Miura, Hideaki Kagaya, Hitoshi Tada, Tsukasa Uno, Norio Yasui-Furukori, Tomonori Tateishi and Toshio Suzuki

    Version of Record online : 20 DEC 2005, DOI: 10.1111/j.1365-2125.2005.02566.x

  18. You have free access to this content
    Effect of low-dose rabeprazole and omeprazole on gastric acidity: results of a double blind, randomized, placebo-controlled, three-way crossover study in healthy subjects

    Alimentary Pharmacology & Therapeutics

    Volume 20, Issue 8, October 2004, Pages: 899–907, S. Bruley des Varannes, H. Gharib, V. Bicheler, R. Bost, B. Bonaz, L. Stanescu, J. C. Delchier and S. Bonnot-Marlier

    Version of Record online : 12 OCT 2004, DOI: 10.1111/j.1365-2036.2004.02176.x

  19. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of rabeprazole in human plasma

    Rapid Communications in Mass Spectrometry

    Volume 19, Issue 16, 30 August 2005, Pages: 2321–2324, Jinchang Huang, Yu Xu, Shu Gao, Lei Rui and Qingxiang Guo

    Version of Record online : 14 JUL 2005, DOI: 10.1002/rcm.2066

  20. Different dosage regimens of rabeprazole for nocturnal gastric acid inhibition in relation to cytochrome P450 2C19 genotype status

    Clinical Pharmacology & Therapeutics

    Volume 76, Issue 4, October 2004, Pages: 290–301, Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Masayoshi Kajimura, Akira Hishida, Masaharu Sakurai, Kyoichi Ohashi and Takashi Ishizaki

    Version of Record online : 26 OCT 2004, DOI: 10.1016/j.clpt.2004.06.008